Tag: JNJ
-
Johnson & Johnson (JNJ) May Be Ready to Rebound
Keep an eye on Johnson & Johnson (JNJ). After pulling back from a high of $173.65, it caught support at $161.99. From here, the stock could again test prior highs if the US FDA grants emergency authorization for its vaccine. With a 66% effective rate in protecting against the virus, JNJ applied for emergency use.…
-
The Top Two Vaccine Stocks to Avoid
There’s no such thing as a perfect trial. Fortunately, there are safeguards in place to stop trials in the event of a mishap. We’ve seen two just this week, which could put a good deal of pressure on their stocks. Hopefully, the events won’t prevent these companies from moving forward for long. Shares of Eli…